Deal-Making
thumbnail
Deal MakingDomain adds CDMO for cancer antibody productionDomain adds CDMO for cancer antibody production
CDMO Chime and Domain Therapeutics have partnered to commercially produce Domain’s antibody candidate DT-7012.
CDMO Chime and Domain Therapeutics have partnered to commercially produce Domain’s antibody candidate DT-7012.